Skip to main content

RT @DrKanikaMonga: - Risk of bDMARD withdrawal higher for TNFi monotherapycompared w/ cs/bDMARD combination- If monotherapy necessary, et…

Social Author Name
Kanika Monga, MD
Tweet Content

- Risk of bDMARD withdrawal higher for TNFi monotherapy compared w/ cs/bDMARD combination - If monotherapy necessary, etanercept should be preferred over infliximab and adalimumab Silvagni E et al. BMJ Open 2018 #ACR19 @RheumNow

×